Some evidence indicates that high pretreatment levels of IL-6 alone in localised CRC [28] and in combination with CRP or YKL-40 in mCRC [45,52] can be indicative of impaired prognosis. The gene discussed is CHI3L1; the disease is colorectal carcinoma.